Clostridium sporogenes (C. sporogenes), as a potential probiotic, metabolizes
tryptophan and produces an anti-inflammatory metabolite, indole-3-propionic
acid (IPA). Herein, we studied the effects of C. sporogenes and its bioactive metabolite, IPA, on skeletal muscle development and chronic
inflammation in mice. In the in vivo study, the muscle tissues and serum samples of mice with C. sporogenes supplementation were used to analyze the effects of C. sporogenes on muscle metabolism; the IPA content was determined by metabonomics and ELISA. In an in vitro study, C2C12 cells were exposed to
lipopolysaccharide (LPS) alone or LPS + IPA to verify the effect of IPA on muscle cell
inflammation by transcriptome, and the involved mechanism was revealed by different functional assays. We observed that C. sporogenes colonization significantly increased the
body weight and muscle
weight gain, as well as the
myogenic regulatory factors' (MRFs) expression. In addition, C. sporogenes significantly improved host IPA content and decreased pro-inflammatory
cytokine levels in the muscle tissue of mice. Subsequently, we confirmed that IPA promoted C2C12 cells' proliferation by activating MRF signaling. IPA also effectively protected against LPS-induced C2C12 cells
inflammation by activating
Pregnane X Receptor and restoring the inhibited miR-26a-2-3p expression. miR-26a-2-3p serves as a novel muscle
inflammation regulatory factor that could directly bind to the 3'-UTR of IL-1β, a key initiator factor in
inflammation. The results suggested that C. sporogenes with its functional metabolite IPA not only helps muscle growth development, but also protects against
inflammation, partly by the IPA/ miR-26a-2-3p /IL-1β cascade.